However, further research should be done to understand the precise functions of placental OPG, information that could reveal unique features of the protein produced by the fetal organ that may lead to developing better and/or new therapeutic strategies to treat MS patients. This evidence concerns the gene TNFRSF11B and myeloid sarcoma.